Guangzhou Promise Biologics Company Limited

Biosimilars: Company Strategies to Capture Value from the Biologics Market

Patents for several biologic blockbusters will expire in the next few years. The arrival of biosimilars, the biologic equivalent of chemical generics, will have an impact on the current biopharmaceuticals market. Five core capabilities have been identified as paramount for those companies aiming to enter the biosimilars market: research and development, manufacturing, supporting activities, mar...

Inferring Company Structure from Limited Available Information

In this paper we present several algorithmic techniques for inferring the structure of a company when only a limited amount of information is available. We consider problems with two types of inputs: the number of pairs of employees with a given property and restricted information about the hierarchical structure of the company. We provide dynamic programming and greedy algorithms for these pro...

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?

Individualising biologic disease-modifying anti-rheumatic drugs (bDMARDs) to maximise outcomes and deliver safe and cost-effective care is a key goal in the management of rheumatoid arthritis (RA). Investigation to identify predictive tools of bDMARD response is a highly active and prolific area of research. In addition to clinical phenotyping, cellular and molecular characterisation of synovia...

What New Drugs, Biologics, and Treatment Approaches Show Promise in Breast Cancer?

A number of new agents are being developed concurrently, including cytotoxins, hormonal agents, and biologic approaches (Table). There are a number of new anthracyclines, particularly liposomal anthracyclines. There are ongoing clinical trials with liposomal daunorubicin and liposomal doxorubicin. At M.D. Anderson, we developed liposomal anamycin, which is a new anthracycline that is not a p-gl...

A Specialty Steel Bar Company Uses Analytics to Determine Available-to-Promise Dates